BioSpace News Archive

Stallergenes Greer, a biopharmaceutical company specialising in treatments for respiratory allergies, announces the submission of a marketing authorisation application for STAGR320, its sublingual house dust mite immunotherapy tablet, via a European decentralized procedure.

Research Published in Nature Communications is Initial Step Towards Developing Fully Human Antibody Therapeutics and Diagnostics for Respiratory Disease COVID-19

Aridis Pharmaceuticals, Inc. announced the enrollment of its first COVID-19 patient in the Company’s ongoing Phase 3 clinical trial of AR-301, a monoclonal antibody against S. aureus induced pneumonia in patients who were already on mechanical ventilators.

DNA Genotek Inc., a leading provider of sample collection kits and end-to-end services and a wholly-owned subsidiary of OraSure Technologies, Inc., announced that its ORAcollect®·RNA kit was included as the collection device for anterior nares samples under a U.S.

Exact Sciences Corp. announced that company management will participate in the following investor conference and invited investors to participate by webcast..

Oragenics, Inc.,, announced its acquisition of Noachis Terra Inc., following its entry into a stock purchase agreement, to develop and commercialize TerraCoV2, a vaccine candidate which could provide specific immunity from the novel coronavirus, the root cause of coronavirus disease 2019.

Oragenics, Inc., announced that it has increased the size of its board of directors and appointed Ms. Kim Murphy to the board, effective May 1, 2020.

Ipsen, a global specialty-driven biopharmaceutical group, IRICoR, a pan-Canadian research commercialization center focused on drug discovery, and Université de Montréal, announced they entered into an option agreement by which Ipsen would acquire an exclusive license for the worldwide rights to a high-value oncology program.

Pharmaceutics International, Inc., a US-based Contract Development and Manufacturing Organization announced it has won the 2020 CDMO Leadership Award and was named the Most Innovative Company in Dosage Solutions by Global Health & Pharma Magazine.

Vaxxel SAS, a French start-up, developing vaccines against respiratory viral infections, announces the acquisition of Transgene’s proprietary DuckCelt®-T17 cell line.